Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma

Leuk Lymphoma. 2013 Jul;54(7):1534-7. doi: 10.3109/10428194.2012.742526. Epub 2012 Nov 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Bone Marrow / pathology
  • Cell Transformation, Neoplastic / drug effects
  • Cell Transformation, Neoplastic / genetics
  • Disease Progression
  • Female
  • Hematopoietic Cell Growth Factors / adverse effects
  • Hematopoietic Cell Growth Factors / therapeutic use*
  • Humans
  • Karyotype*
  • Leukemic Infiltration
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / genetics*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / etiology*
  • Remission Induction

Substances

  • Hematopoietic Cell Growth Factors